Deutsche Bank
AXDX

Deutsche Bank’s Accelerate Diagnostics AXDX Stock Holding History

Deutsche Bank’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,909
Closed -$28K – 4131
2022
Q1 		$28K Sell
1,909
-212
-10% -$6.04K ﹤0.01% 3990
2021
Q4 		$111K Buy
2,121
+105
+5% +$5.85K ﹤0.01% 3660
2021
Q3 		$118K Sell
2,016
-56
-3% -$3.65K ﹤0.01% 3830
2021
Q2 		$167K Sell
2,072
-66
-3% -$5.25K ﹤0.01% 3886
2021
Q1 		$178K Sell
2,138
-193
-8% -$19.6K ﹤0.01% 3697
2020
Q4 		$177K Buy
2,331
+661
+40% +$59.2K ﹤0.01% 3534
2020
Q3 		$178K Buy
1,670
+87
+5% +$12.1K ﹤0.01% 3281
2020
Q2 		$240K Buy
1,583
+633
+67% +$62.4K ﹤0.01% 3043
2020
Q1 		$79K Sell
950
-43
-4% -$6.05K ﹤0.01% 3346
2019
Q4 		$167K Buy
993
+206
+26% +$34K ﹤0.01% 3328
2019
Q3 		$145K Sell
787
-853
-52% -$165K ﹤0.01% 3374
2019
Q2 		$373K Sell
1,640
-1,686
-51% -$330K ﹤0.01% 3465
2019
Q1 		$697K Sell
3,326
-44
-1% -$8.25K ﹤0.01% 3236
2018
Q4 		$386K Sell
3,370
-2,776
-45% -$411K ﹤0.01% 3495
2018
Q3 		$1.41M Buy
6,146
+990
+19% +$219K ﹤0.01% 3077
2018
Q2 		$1.15M Buy
5,156
+1,398
+37% +$313K ﹤0.01% 3333
2018
Q1 		$858K Sell
3,758
-27,489
-88% -$7.22M ﹤0.01% 3406
2017
Q4 		$8.19M Buy
31,247
+28,910
+1,237% +$6.78M 0.01% 1648
2017
Q3 		$523K Sell
2,337
-1,797
-43% -$441K ﹤0.01% 3396
2017
Q2 		$1.13M Buy
4,134
+3,563
+624% +$966K ﹤0.01% 2948
2017
Q1 		$137K Sell
571
-1,023
-64% -$234K ﹤0.01% 3778
2016
Q4 		$329K Sell
1,594
-2,996
-65% -$711K ﹤0.01% 3414
2016
Q3 		$1.25M Sell
4,590
-2,138
-32% -$473K ﹤0.01% 2676
2016
Q2 		$966K Buy
6,728
+6,103
+976% +$818K ﹤0.01% 2920
2016
Q1 		$88K Buy
625
+84
+16% +$11.9K ﹤0.01% 4073
2015
Q4 		$115K Sell
541
-149
-22% -$27.2K ﹤0.01% 3996
2015
Q3 		$110K Sell
690
-13
-2% -$2.81K ﹤0.01% 4069
2015
Q2 		$180K Buy
703
+695
+8,688% +$166K ﹤0.01% 3942
2015
Q1 		$0 Sell
8
-474
-98% -$99K ﹤0.01% 5124
2014
Q4 		$92K Sell
482
-371
-43% -$79.4K ﹤0.01% 4770
2014
Q3 		$182K Sell
853
-1,553
-65% -$302K ﹤0.01% 4123
2014
Q2 		$624K Buy
2,406
+1,929
+404% +$421K ﹤0.01% 3309
2014
Q1 		$103K Buy
477
+266
+126% +$39.4K ﹤0.01% 4224
2013
Q4 		$25K Sell
211
-1,116
-84% -$149K ﹤0.01% 4643
2013
Q3 		$177K Buy
1,327
+707
+114% +$63.1K ﹤0.01% 4181
2013
Q2 		$50K Buy
+620
New +$46K ﹤0.01% 4506

Other funds holding AXDX

GAM
Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
CIA
Cladis Investment Advisory Billings, Montana $182M AUM 33.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BAM
Belpointe Asset Management Reno, Nevada $2.74B AUM 20.71% 1-Year Est. Return

Deutsche Bank's AXDX Position: Q2 2022 in Review

Deutsche Bank sold out of Accelerate Diagnostics (AXDX) in Q2 2022, closing a stake of 1,909 shares — an estimated $28K sold.

Deutsche Bank first reported a position in AXDX in Q2 2013 and held it in 36 quarters. The position peaked at $8.19M in Q4 2017. 74 funds tracked by Wall St. Rank hold AXDX as of Q2 2022.

  • Deutsche Bank reported no remaining Accelerate Diagnostics position as of Q2 2022 after selling out during the quarter.
  • Deutsche Bank sold 1,909 Accelerate Diagnostics shares in Q2 2022, an estimated $28K.
  • Deutsche Bank first reported a position in Accelerate Diagnostics in Q2 2013 and held it in 36 quarters.
  • Deutsche Bank's Accelerate Diagnostics position peaked at $8.19M in Q4 2017.
  • 74 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q2 2022.

Based on Deutsche Bank's 13F filing for Q2 2022, filed 11 Aug 2022.